| Dox | Doxorubicin |
| EPR | Enhanced permeation and retention |
| ER | Estrogen receptor |
| FA | Folic acid |
| FDA | Food and Drug Administration |
| HER2 | Human epidermal growth receptor 2 |
| IV | Intravenous |
| miRNA | Micro ribonucleic acid |
| NPs | Nanoparticles |
| PDT | Photodynamic treatment |
| PAMAM | Polyamidoamine |
| PEG | Polyethylene glycol |
| PLA | Polylactic acid |
| PR | Progesterone receptor |
| PS | Photosensitizer |
| QDs | Quantum dots |
| ROS | Reactive oxygen species |
| siRNA | Small interfering ribonucleic acid |
| TNBC | Triple-negative breast cancer |